Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study

Por Herttua, Kimmo, Tabák, Adam G., Martikainen, Pekka, Vahtera, Jussi, Kivimäki, Mika
Publicado em 2013

Prediabetes: A high-risk state for developing diabetes

Por Tabák, Adam G., Herder, Christian, Rathmann, Wolfgang, Brunner, Eric J., Kivimäki, Mika
Publicado em 2012

Maternal Glycemia and Risk of Large-for-Gestational-Age Babies in a Population-Based Screening

Por Kerényi, Zsuzsa, Tamás, Gyula, Kivimäki, Mika, Péterfalvi, Andrea, Madarász, Eszter, Bosnyák, Zsolt, Tabák, Adam G.
Publicado em 2009

Patterns of Obesity Development before the Diagnosis of Type 2 Diabetes: The Whitehall II Cohort Study

Por Vistisen, Dorte, Witte, Daniel R., Tabák, Adam G., Herder, Christian, Brunner, Eric J., Kivimäki, Mika, Færch, Kristine
Publicado em 2014

Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes: The Whitehall II Study

Por Herder, Christian, Brunner, Eric J., Rathmann, Wolfgang, Strassburger, Klaus, Tabák, Adam G., Schloot, Nanette C., Witte, Daniel R.
Publicado em 2009

Physical activity and inflammatory markers over 10 years follow up in men and women from the Whitehall II cohort study

Por Hamer, Mark, Sabia, Severine, Batty, G. David, Shipley, Martin J., Tabák, Adam G, Singh-Manoux, Archana, Kivimaki, Mika
Publicado em 2012

Effect of secular trends on age-related trajectories of cardiovascular risk factors: the Whitehall II longitudinal study 1985–2009

Por Hulmán, Adam, Tabák, Adam G, Nyári, Tibor A, Vistisen, Dorte, Kivimäki, Mika, Brunner, Eric J, Witte, Daniel R
Publicado em 2014

Psychological Distress and Incidence of Type 2 Diabetes in High-Risk and Low-Risk Populations: The Whitehall II Cohort Study

Por Virtanen, Marianna, Ferrie, Jane E., Tabak, Adam G., Akbaraly, Tasnime N., Vahtera, Jussi, Singh-Manoux, Archana, Kivimäki, Mika
Publicado em 2014

Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study

Por Tuligenga, Richard H, Dugravot, Aline, Tabák, Adam G, Elbaz, Alexis, Brunner, Eric J, Kivimäki, Mika, Singh-Manoux, Archana
Publicado no Lancet Diabetes Endocrinol (2014)

Antidepressant Medication Use, Weight Gain, and Risk of Type 2 Diabetes: A population-based study

Por Kivimäki, Mika, Hamer, Mark, Batty, G. David, Geddes, John R., Tabak, Adam G., Pentti, Jaana, Virtanen, Marianna, Vahtera, Jussi
Publicado em 2010

Association of Lifecourse Socioeconomic Status with Chronic Inflammation and Type 2 Diabetes Risk: The Whitehall II Prospective Cohort Study

Por Stringhini, Silvia, Batty, G. David, Bovet, Pascal, Shipley, Martin J., Marmot, Michael G., Kumari, Meena, Tabak, Adam G., Kivimäki, Mika
Publicado em 2013

Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study

Por Ikehara, Satoyo, Tabák, Adam G., Akbaraly, Tasnime N., Hulmán, Adam, Kivimäki, Mika, Forouhi, Nita G., Iso, Hiroyasu, Brunner, Eric J.
Publicado no Diabetologia (2014)

Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes: Whitehall II Prospective Cohort Study

Por Carstensen, Maren, Herder, Christian, Kivimäki, Mika, Jokela, Markus, Roden, Michael, Shipley, Martin J., Witte, Daniel R., Brunner, Eric J., Tabák, Adam G.
Publicado em 2010

Association between Change in Body Composition and Change in Inflammatory Markers: An 11-Year Follow-Up in the Whitehall II Study

Por Fransson, Eleonor I., Batty, G. David, Tabák, Adam G., Brunner, Eric J., Kumari, Meena, Shipley, Martin J., Singh-Manoux, Archana, Kivimäki, Mika
Publicado em 2010

Adiponectin Trajectories Before Type 2 Diabetes Diagnosis: Whitehall II study

Por Tabák, Adam G., Carstensen, Maren, Witte, Daniel R., Brunner, Eric J., Shipley, Martin J., Jokela, Markus, Roden, Michael, Kivimäki, Mika, Herder, Christian
Publicado em 2012

Little Change in Diet After Onset of Type 2 Diabetes, Metabolic Syndrome, and Obesity in Middle-Aged Adults: 11-Year Follow-up Study

Por Akbaraly, Tasnime N., Tabak, Adam G., Shipley, Martin J., Mura, Thibault, Singh-Manoux, Archana, Ferrie, Jane E., Batty, G. David, Kivimaki, Mika
Publicado no Diabetes Care (2016)

Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whit...

Por Hulman, Adam, Simmons, Rebecca K., Brunner, Eric J., Witte, Daniel R., Færch, Kristine, Vistisen, Dorte, Ikehara, Satoyo, Kivimaki, Mika, Tabák, Adam G.
Publicado no Diabetologia (2017)

Justice at Work and Metabolic Syndrome: the Whitehall II Study

Por Gimeno, David, Tabák, Ádám G., Ferrie, Jane E., Shipley, Martin J., De Vogli, Roberto, Elovainio, Marko, Vahtera, Jussi, Marmot, Michael G., Kivimäki, Mika
Publicado em 2009

Noninvasive Evaluation of Neural Impairment in Subjects With Impaired Glucose Tolerance

Por Putz, Zsuzsanna, Tabák, Ádám G, Tóth, Nelli, Istenes, Ildikó, Németh, Nóra, Gandhi, Rajiv A., Hermányi, Zsolt, Keresztes, Katalin, Jermendy, György, Tesfaye, Solomon, Kempler, Péter
Publicado em 2009

Metabolic Syndrome Over 10 Years and Cognitive Functioning in Late Midlife: The Whitehall II study

Por Akbaraly, Tasnime N., Kivimaki, Mika, Shipley, Martin J., Tabak, Adam G., Jokela, Markus, Virtanen, Marianna, Marmot, Michael G., Ferrie, Jane E., Singh-Manoux, Archana
Publicado em 2010